Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody▿

Identifieur interne : 001D96 ( Ncbi/Curation ); précédent : 001D95; suivant : 001D97

Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody▿

Auteurs : Luis G. Giménez [Espagne] ; Jose Rojas [Espagne] ; Almudena Rojas [Espagne] ; Joaquín Mendoza [Espagne] ; Ana G. Camacho [Espagne]

Source :

RBID : PMC:2643541

Descripteurs français

English descriptors

Abstract

A new enzyme-linked immunosorbent assay (ELISA)-based immunoglobulin G (IgG)-plus-IgM antibody detection test for severe acute respiratory syndrome (SARS) has been developed by using a cocktail of four recombinant polypeptides as the antigen. These recombinant fragments were designed as parts of two different structural proteins from SARS-associated coronavirus (SARS-CoV). One recombinant polypeptide, S251-683, was designed as part of the spike glycoprotein, and the other three polypeptides comprised almost the whole nucleocapsid protein, avoiding the last 25 C-terminal amino acids. Immunization with a cocktail of these four polypeptides yielded a specific polyclonal antibody that is able to recognize SARS-CoV-infected cells by an immunofluorescence assay. This polypeptide cocktail was also used to set up an ELISA-based IgG-plus-IgM antibody detection test, which showed 99% specificity and 90% sensitivity upon evaluation using sera from 100 healthy negative controls and 20 SARS patients. Separate immunoreactivity assays with each recombinant polypeptide demonstrated that a combination of N and S protein fragments was more suitable than the individual peptides for developing a serological assay for SARS-CoV.


Url:
DOI: 10.1128/CVI.00252-08
PubMed: 19038782
PubMed Central: 2643541

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:2643541

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody
<xref ref-type="fn" rid="fn1"></xref>
</title>
<author>
<name sortKey="Gimenez, Luis G" sort="Gimenez, Luis G" uniqKey="Gimenez L" first="Luis G." last="Giménez">Luis G. Giménez</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rojas, Jose" sort="Rojas, Jose" uniqKey="Rojas J" first="Jose" last="Rojas">Jose Rojas</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rojas, Almudena" sort="Rojas, Almudena" uniqKey="Rojas A" first="Almudena" last="Rojas">Almudena Rojas</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mendoza, Joaquin" sort="Mendoza, Joaquin" uniqKey="Mendoza J" first="Joaquín" last="Mendoza">Joaquín Mendoza</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Camacho, Ana G" sort="Camacho, Ana G" uniqKey="Camacho A" first="Ana G." last="Camacho">Ana G. Camacho</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">19038782</idno>
<idno type="pmc">2643541</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643541</idno>
<idno type="RBID">PMC:2643541</idno>
<idno type="doi">10.1128/CVI.00252-08</idno>
<date when="2008">2008</date>
<idno type="wicri:Area/Pmc/Corpus">000634</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000634</idno>
<idno type="wicri:Area/Pmc/Curation">000634</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000634</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000E29</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000E29</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:19038782</idno>
<idno type="wicri:Area/PubMed/Corpus">001A24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A24</idno>
<idno type="wicri:Area/PubMed/Curation">001A24</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A24</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001899</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001899</idno>
<idno type="wicri:Area/Ncbi/Merge">001D96</idno>
<idno type="wicri:Area/Ncbi/Curation">001D96</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody
<xref ref-type="fn" rid="fn1"></xref>
</title>
<author>
<name sortKey="Gimenez, Luis G" sort="Gimenez, Luis G" uniqKey="Gimenez L" first="Luis G." last="Giménez">Luis G. Giménez</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rojas, Jose" sort="Rojas, Jose" uniqKey="Rojas J" first="Jose" last="Rojas">Jose Rojas</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rojas, Almudena" sort="Rojas, Almudena" uniqKey="Rojas A" first="Almudena" last="Rojas">Almudena Rojas</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Mendoza, Joaquin" sort="Mendoza, Joaquin" uniqKey="Mendoza J" first="Joaquín" last="Mendoza">Joaquín Mendoza</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Camacho, Ana G" sort="Camacho, Ana G" uniqKey="Camacho A" first="Ana G." last="Camacho">Ana G. Camacho</name>
<affiliation wicri:level="1">
<nlm:aff id="aff0">Laboratorios Vircell, SL, Granada, Spain</nlm:aff>
<country xml:lang="fr">Espagne</country>
<wicri:regionArea>Laboratorios Vircell, SL, Granada</wicri:regionArea>
<wicri:noRegion>Granada</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Clinical and Vaccine Immunology : CVI</title>
<idno type="ISSN">1556-6811</idno>
<idno type="eISSN">1556-679X</idno>
<imprint>
<date when="2008">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antibodies, Viral (blood)</term>
<term>Antigens, Viral</term>
<term>Enzyme-Linked Immunosorbent Assay (methods)</term>
<term>Humans</term>
<term>Immunoglobulin G (blood)</term>
<term>Immunoglobulin M (blood)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Nucleocapsid Proteins (immunology)</term>
<term>Recombinant Proteins</term>
<term>SARS Virus (immunology)</term>
<term>Sensitivity and Specificity</term>
<term>Severe Acute Respiratory Syndrome (diagnosis)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Anticorps antiviraux (sang)</term>
<term>Antigènes viraux</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Humains</term>
<term>Immunoglobuline G (sang)</term>
<term>Immunoglobuline M (sang)</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Protéines nucléocapside (immunologie)</term>
<term>Protéines recombinantes</term>
<term>Sensibilité et spécificité</term>
<term>Syndrome respiratoire aigu sévère (diagnostic)</term>
<term>Test ELISA ()</term>
<term>Virus du SRAS (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en">
<term>Antibodies, Viral</term>
<term>Immunoglobulin G</term>
<term>Immunoglobulin M</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Membrane Glycoproteins</term>
<term>Nucleocapsid Proteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en">
<term>Antigens, Viral</term>
<term>Recombinant Proteins</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr">
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Protéines nucléocapside</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en">
<term>Enzyme-Linked Immunosorbent Assay</term>
</keywords>
<keywords scheme="MESH" qualifier="sang" xml:lang="fr">
<term>Anticorps antiviraux</term>
<term>Immunoglobuline G</term>
<term>Immunoglobuline M</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Humans</term>
<term>Sensitivity and Specificity</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Antigènes viraux</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Humains</term>
<term>Protéines recombinantes</term>
<term>Sensibilité et spécificité</term>
<term>Test ELISA</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>A new enzyme-linked immunosorbent assay (ELISA)-based immunoglobulin G (IgG)-plus-IgM antibody detection test for severe acute respiratory syndrome (SARS) has been developed by using a cocktail of four recombinant polypeptides as the antigen. These recombinant fragments were designed as parts of two different structural proteins from SARS-associated coronavirus (SARS-CoV). One recombinant polypeptide, S251-683, was designed as part of the spike glycoprotein, and the other three polypeptides comprised almost the whole nucleocapsid protein, avoiding the last 25 C-terminal amino acids. Immunization with a cocktail of these four polypeptides yielded a specific polyclonal antibody that is able to recognize SARS-CoV-infected cells by an immunofluorescence assay. This polypeptide cocktail was also used to set up an ELISA-based IgG-plus-IgM antibody detection test, which showed 99% specificity and 90% sensitivity upon evaluation using sera from 100 healthy negative controls and 20 SARS patients. Separate immunoreactivity assays with each recombinant polypeptide demonstrated that a combination of N and S protein fragments was more suitable than the individual peptides for developing a serological assay for SARS-CoV.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001D96 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001D96 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:2643541
   |texte=   Development of an Enzyme-Linked Immunosorbent Assay-Based Test with a Cocktail of Nucleocapsid and Spike Proteins for Detection of Severe Acute Respiratory Syndrome-Associated Coronavirus-Specific Antibody▿ 
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:19038782" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021